(firstQuint)Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines.

 This is a double-blind, randomized, parallel-group, controlled, repeat dose, single center study to evaluate the safety and efficacy of repeat application of RT001 in at least 30 subjects with moderate to severe lateral canthal lines.

 Subjects will be randomized to 1 of 2 treatment groups in a 1:1 ratio (RT001 Dose A or vehicle control).

.

 Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines@highlight

The purpose of this study is to determine the safety and efficacy of 2 sequential doses of RT001 compared to vehicle control following applications at Baseline (Day 0) and Week 2.

